Navigation Links
GenVec Presents Research on New Ad35 Adenovector at ARVO

if any, of GenVec's proposed product candidates; dependence on the efforts of third parties; dependence on intellectual property; and risks that we may lack the financial resources and access to capital to fund our operations. Further information on the factors and risks that could affect GenVec's business, financial conditions and results of operations, are contained in GenVec's filings with the U.S. Securities and Exchange Commission (SEC), which are available at www.sec.gov. These forward-looking statements speak only as of the date of this press release, and GenVec assumes no duty to update forward-looking statements.

Contact

GenVec, Inc.
Sharon L. Weinstein
Director, Investor Relations and Corporate Communications
240-632-5511
sweinstein@genvec.com


'"/>




Page: 1 2 3

Related medicine technology :

1. GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO
2. GenVec Announces New Research at AACR on Selectivity and Mechanism of Action of TNF-Based Anti-Cancer Therapy
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: GenVec Presents Research New Adenovector ARVO
(Date:7/6/2015)... July 6, 2015  OncoSec Medical Inc. ("OncoSec") (NASDAQ: ... immunotherapies, today announced the appointment of Joann V. ... President of Market Development, effective July 6, 2015. In ... designing, and executing on the company,s market and product ... very excited to welcome Joann to the OncoSec team ...
(Date:7/5/2015)... -- Nihon University is pleased to announce that ... "Medicine Definitely Jumps Up with 8K" will be ... Tokyo, Japan . Many experts on imaging ... their achievements and future prospects on progress of ... 8K technology. (Documentation: http://prw.kyodonews.jp/prwfile/release/M000079/201507031722/_prw_OA1fl_Xy4Q5W4x.pdf ) ...
(Date:7/4/2015)... 4, 2015 Adding SIR-Spheres® ... with unresectable metastatic colorectal cancer in the liver ... Patients with unresectable metastatic colorectal cancer ... experienced the greatest improvement in Progression-Free Survival (PFS) ... Y-90 resin microspheres to a current first-line chemotherapy ...
Breaking Medicine Technology:OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 2OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 3Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4
... August 2, 2010 Almac today,announced the launch of ... meet the needs of the biopharma industry. , ... ... enable them to better understand their drug, improve,their drug,s success rate, ...
... Corporation (NYSE: CFN ) today announced plans to release fourth quarter ... on the New York Stock Exchange. , , ... will host a webcast and conference call on Aug. 10 at 2 ... its fourth quarter and fiscal 2010, ended on June 30, 2010 . To access ...
Cached Medicine Technology:Almac Launch Biomarkers for Biopharma 2Almac Launch Biomarkers for Biopharma 3CareFusion Will Host an Earnings Conference Call on Aug. 10 to Discuss the Results for the Fourth Quarter and Fiscal 2010 2
(Date:7/5/2015)... ... July 06, 2015 , ... ... market, is excited to announce the next generation of PrimeStar Individual Dental Insurance. ... to now include two network options—Maximum Allowable Charge (MAC) and usual, customary and ...
(Date:7/5/2015)... ... July 05, 2015 , ... World ... Weed Master, a landscaping invention that effectively removes weeds without harming man ... says Scott Cooper, CEO and Creative Director of World Patent Marketing. "It is ...
(Date:7/4/2015)... ... July 05, 2015 , ... Dating a real millionaire online can be ... millionaire dating service and strives to remove the worries from meeting partners. Recently, ... dating app of 2015 and readers have responded with excitement. , “There's ...
(Date:7/4/2015)... ... ... When a hacker gains access to someone’s email account, it can lead to all sorts ... the FTC issued a scam alert about a social engineering scam which cons ... reset instigated by the hacker. All they have to do is click for a ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... July 2nd creating a buzz of media attention. In an effort to spread ... HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people are feeling overwhelmed by stress ...
Breaking Medicine News(10 mins):Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3
... ST. LOUIS A residential summer weight-loss camp markedly ... edition of Pediatrics reports. A Saint ... body mass index (BMI), physical fitness and blood pressure. ... to redirect the social environment to be successful," said ...
... diabetes may be related to trend toward less sleep, ... Adding to the many reasons why people should get adequate ... cause insulin resistance, a component of type 2 diabetes. , ... measured after a night of normal sleep (about eight hours) ...
... timing change, researchers say , THURSDAY, May 6 (HealthDay News) ... D supplement if you take it with your largest meal, ... 17 patients with vitamin D deficiency who weren,t getting better ... the patients were told to take vitamin D supplements with ...
... of researchers has discovered molecular evidence that may explain ... not respond to drugs designed to target this important ... Cancer Conference in Brussels, Belgium, could have an important ... in HER2 over-expressing breast cancer. The over-expression of ...
... million women take hormone therapies, which are often a ... from inactive ovaries. Progestin is a hormone that is ... therapy on the uterus. In studies sponsored by the ... estrogen and progestin in hormone therapies increase the risk ...
... ... fraud if an employee responds falsely to a confirmation request. While paper confirmations make ... the standards-setting boards supporting the use of secure electronic confirmations now give companies a better ... ...
Cached Medicine News:Health News:The biggest winners: Summer campers 2Health News:One Sleepless Night Ups Insulin Resistance 2Health News:Estrogen receptor status of HER2+ breast cancer correlates with response to anti-HER therapies 2Health News:Breast cancer metastasis increases after estrogen and progestin hormone therapies, MU study finds 2Health News:Brian Fox to Speak on Audit Confirmation Fraud at the 2010 IAPP Annual Forum and Expo 2
... The Ulti-Mist™ HME product line has the ... pediatrics to adults and from intubated patients ... superior humidification for both anesthesia and critical ... HME/Filters provide maximum protection for patients and ...
The Pall High Performance HME is a high efficiency heat and moisture exchanger, indicated to protect patients against the potential risks of ventilation with dry and cold gases....
Passive heat and moisture exchangers for respiratory applications....
Passive heat and moisture exchangers for respiratory applications....
Medicine Products: